Naproxen Chelonia Healthcare (Naproxen Bp)

Naproxen works by reversibly blocking the cyclooxygenase‑1 and cyclooxygenase‑2 (COX‑1/COX‑2) enzymes. This inhibition reduces the synthesis of prostaglandins, which are mediators of pain, inflammation, and fever. Lower prostaglandin levels lead to decreased sensitisation of nerve endings and reduced inflammatory swelling.

The specific dose of Naproxen Chelonia Healthcare is determined by the prescribing clinician based on the patient’s condition, age, weight, and overall health status. Healthcare professionals tailor the regimen to achieve optimal pain control while minimising potential risks.

Safety of naproxen in pregnancy and lactation depends on the trimester and clinical judgement. Generally, it is avoided in the third trimester because of potential fetal cardiovascular effects. Breastfeeding mothers should consult a healthcare provider, as naproxen can be excreted in small amounts in milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Both naproxen and ibuprofen belong to the NSAID class and share similar mechanisms of COX inhibition. Naproxen has a longer half‑life, often allowing twice‑daily dosing, whereas ibuprofen typically requires three‑to‑four doses per day. Choice between them depends on patient tolerance, dosing convenience, and specific risk‑benefit considerations.

Naproxen Chelonia Healthcare should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

The medication is taken orally, usually with a full glass of water. It can be taken with or without food; however, taking it with food or milk may reduce gastrointestinal discomfort. Patients should follow the prescribing clinician’s instructions regarding timing and frequency.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, severe skin reactions (e.g., Stevens‑Johnson syndrome), and renal impairment. Patients should seek immediate medical attention if they experience signs of bleeding, chest pain, sudden weakness, or severe skin rash.

Naproxen is contraindicated in individuals with known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulcer disease, severe heart failure, or those who have had recent coronary artery bypass graft surgery. It should also be avoided in patients with significant renal or hepatic impairment unless specifically directed by a physician.